Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App





Alcor Demonstrates State-Of-The-Art ESR Analyzers at MEDICA 2022

By LabMedica International staff writers
Posted on 14 Nov 2022

ALCOR Scientific (Smithfield, RI, USA) is demonstrating its innovative diagnostic instruments and medical devices for the healthcare industry at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany. More...

At MEDICA 2022, ALCOR is presenting iSED, a 20-position, fully automated ESR analyzer that produces results in 20 seconds using just 100µL of sample taken directly from the primary EDTA tube. This small sample volume makes the iSED ideal for pediatric and low volume samples. Primary tube sampling ensures sample and result traceability and decreases biohazard risk to the user. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS.

ALCOR is also demonstrating the miniiSED, a single position, fully automated ESR analyzer that uses the same technology as the iSED in a smaller footprint. The miniiSED produces results in just 15 seconds using only 100 µL of sample taken directly from the primary EDTA tube. The results can be printed, saved to onboard memory, and/or transmitted directly to the LIS. With the small sample volume and fast turnaround time in a minimal footprint, the miniiSED is the ideal ESR analyzer for small hospital laboratories, emergency rooms, specialty testing laboratories and POLs.

Related Links:
ALCOR Scientific


New
Gold Member
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
Collection and Transport System
PurSafe Plus®
Human Estradiol Assay
Human Estradiol CLIA Kit
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LungCanSeek demonstrated an overall sensitivity of 83.5% and specificity of 90.3% in detecting lung cancer (Photo courtesy of AdobeStock)

New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer

Lung cancer remains the leading cause of cancer-related deaths worldwide, largely because most cases are diagnosed at advanced stages when treatment options are limited. Early detection significantly improves... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The TriVerity IVD test includes the TriVerity cartridge and the Myrna instrument (Photo courtesy of Inflammatix)

Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients

When a patient enters the emergency department in critical condition, clinicians must rapidly decide whether the patient has an infection, whether it is bacterial or viral, and whether immediate treatment... Read more

Industry

view channel
Image: The collaboration supports clinical validation and regulatory submissions of the new T1D 4-plex assay on Revvity’s GSP instrument (Photo courtesy of Revvity)

Revvity and Sanofi Collaborate on Program to Revolutionize Early Detection of Type 1 Diabetes

Type 1 diabetes (T1D) is a lifelong autoimmune condition in which the immune system destroys the pancreas’s insulin-producing beta cells, leading to dependence on insulin therapy. Early detection is critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.